Status:
COMPLETED
Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
Society of Abdominal Radiology
Conditions:
Bladder Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overarching goal of this project is to explore whether associations exist between metrics obtained from PET/MRI incorporating advanced MRI sequences and features of bladder cancer, including grade...
Detailed Description
The investigators will assess an advanced non-Gaussian diffusion-weighted imaging (DWI) model termed diffusion kurtosis imaging, multi-echo T2 mapping, dynamic contrast-enhanced (DCE) MRI using a moti...
Eligibility Criteria
Inclusion
- Histologic or imaging evidence of urothelial carcinoma of the bladder
- Age ≥ 18 years of age
- If female of childbearing potential, pregnancy test is negative. (In these instances, the patient will need to provide documentation of negative pregnancy test results.)
Exclusion
- Inability to tolerate MRI including conditions such as claustrophobia or inability to lay flat for \> 45 minutes.
- Presence of pacemaker/implantable cardiac device (ICD) or perfusion pumps
- Ferromagnetic implants such as aneurysm clips, surgical clips, prostheses, artificial heart, valves with steel parts, metal fragments, shrapnel, bullets, tattoos near the eye, or steel implants.
- Substance abuse, medical, psychological, or social conditions that may interfere with the patient's participation in the study
Key Trial Info
Start Date :
May 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT02287701
Start Date
May 1 2014
End Date
September 1 2016
Last Update
August 14 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Medical Center
New York, New York, United States, 10016